Fundraising FoxFind your path to Mark
Sign up to see every warm intro you have to Mark
- Paths you didn't know you had: your email and LinkedIn already hold routes to Mark. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investments
Investor
Aura BiosciencesDisc MedicineEnsomaEthyreal BioEvommuneHarpoon TherapeuticsImaraIterum TherapeuticsOttimo PharmaVelosbioVicebio
Per curated public sources.
Colleagues at JMI Equity
AJ Hull
Associate at JMI Equity
Aleef Mahmoud
Investor at JMI Equity
Alex Filipova
Analyst at JMI Equity
Alex Giummo
Associate at JMI Equity
Alex Raines
Senior Associate at JMI Equity
Alexandra Noack
Executive Assistant at Whitecap Venture Partners
Alia Piccinni
Analyst at JMI Equity
Anastasiya Pasheyeva
Vice President at JMI Equity
Frequently asked questions
- Who is Mark Chin?
- Investor at JMI Equity
- Where does Mark Chin work?
- Mark Chin is at JMI Equity.
- What check size does Mark Chin write?
- Mark Chin typically writes checks of $100K – $5M.
- What companies has Mark Chin invested in?
- Investments tracked here include Aura Biosciences, Disc Medicine, Ensoma, Ethyreal Bio, Evommune, Harpoon Therapeutics, Imara, Iterum Therapeutics, Ottimo Pharma, Velosbio, Vicebio.
About this profile. Compiled from public sources — JMI Equity's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights